NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT04704258
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- AorticLab Srl
- Registry
-
NCT04704258
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Italy
- Registry status
- Completed
Technical summary
Registry record NCT04704258. Allocation not applicable; no masking; primary purpose other. Start 2021-05-03 (actual); primary completion 2023-06-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NAUTILUS CE-mark Trial of the FLOWer Cerebral Embolic Protection Device
- Acronym
- NAUTILUS
- Condition
- Aortic Valve Stenosis
- Condition
- Intracranial Embolism and Thrombosis
- Intervention (Procedure)
- TAVI (Transcatheter Aortic Valve Implant)
- Intervention (Device)
- FLOWer Embolic Protection System
- Lead sponsor
- AorticLab Srl
- Collaborator
- Meditrial Europe Ltd.
Record details
- Record id
cardio:ct-nct04704258- Content hash
0135014eac3491296a5ac848fd427129c0014a55dd39b7dc9742edcf387b026c